ArticleClinical rheumatology2025
Comparative analysis of clinical features in diffuse and focal enlargement of IgG4-related autoimmune pancreatitis: a single-center retrospective study.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Clinical characteristics of IgG4-related disease patients with different serum IgG4 levels: A single-center retrospective study.The Journal of international medical research · 2026Observational
- Case Report: Recurrent abdominal pain with elevated pancreatic enzymes in type 2 diabetes mellitus: a case of IgG4-related autoimmune pancreatitis misdiagnosed as acute pancreatitis.Frontiers in endocrinology · 2026Article
- Article
- Case Report: IgG4-related autoimmune pancreatitis presenting as an infiltrative cystic-solid pancreatic mass: lessons from a diagnostic pitfall.Frontiers in medicine · 2026Article
- Elevated CA19-9 in IgG4-Related Autoimmune Pancreatitis: A Single-Center Retrospective Cohort Study.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundIgG4-related autoimmune pancreatitis (IgG4-AIP) is a rare inflammatory pancreatic disorder mediated by autoimmune mechanisms, primarily characterized by two forms of presentation: diffuse enlargement and focal enlargement. This study aims to analyze the clinical characteristics of diffuse and focal enlargement in IgG4-AIP, thereby enhancing clinicians' understanding of the differences between these two patient groups and ultimately improving patient outcomes.
methodsThis study conducted a retrospective analysis of the clinical data from 40 patients with IgG4-AIP admitted to Yichang Central People's Hospital between January 2019 and December 2024.
resultsAmong the 40 patients with IgG4-AIP, 23 (57.50%) presented with diffuse pancreatic enlargement, while 17 (42.50%) exhibited focal pancreatic enlargement. In the diffuse enlargement group, the most common clinical symptom was abdominal pain (13/23 patients, 56.52%), whereas the focal enlargement group predominantly presented with jaundice (11/17 patients, 64.71%). Additionally, patients in the focal enlargement group were more likely to be misdiagnosed as pancreatic tumors (47.06% vs. 13.04%, P < 0.05). In the focal enlargement group, serum levels of gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP) were significantly elevated compared to the diffuse enlargement group, while serum albumin (ALB) levels were markedly reduced (P < 0.05). The incidence of pancreatic dilatation was significantly higher in the focal enlargement group compared to the diffuse enlargement group (47.06% vs. 13.04%, P < 0.05).
conclusionsThe clinical features of focal enlargement in IgG4-AIP are notably more complex. Clinicians should conduct a thorough analysis of the two presentation forms to develop personalized treatment strategies, thereby improving the prognosis for patients with different manifestations of IgG4-AIP.
Indexed as
Identifiers
40866765What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.